Logo image of AGL

AGILON HEALTH INC (AGL) Stock Earnings & Estimates

USA - NYSE:AGL - US00857U1079 - Common Stock

1.03 USD
-0.08 (-7.21%)
Last: 9/30/2025, 8:04:00 PM
1.0487 USD
+0.02 (+1.82%)
After Hours: 9/30/2025, 8:04:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
AGL revenue by date.AGL revenue by date.
2.708B
47.70%
4.316B
59.38%
6.061B
40.41%
5.873B
-3.09%
6.247B
6.37%
7.016B
12.31%
8.061B
14.89%
9.607B
19.18%
10.975B
14.24%
10.467B
-4.63%
EBITDA
YoY % growth
AGL ebitda by date.AGL ebitda by date.
-106.63M
71.89%
-211.972M
-98.79%
-264.071M
-24.58%
-181.332M
31.33%
-77.682M
57.16%
-15.784M
79.68%
98.255M
722.50%
110.09M
12.05%
199.27M
81.01%
309.16M
55.15%
EBIT
YoY % growth
AGL ebit by date.AGL ebit by date.
-120.4M
69.44%
-232.133M
-92.80%
-288.534M
-24.30%
-321.214M
-11.33%
-199.781M
37.80%
-152.849M
23.49%
-99.687M
34.78%
-33.633M
66.26%
48.48M
244.14%
149.68M
208.75%
Operating Margin
AGL operating margin by date.AGL operating margin by date.
-4.45%-5.38%-4.76%-5.47%-3.20%-2.18%-1.24%-0.35%0.44%1.43%
EPS
YoY % growth
AGL eps by date.AGL eps by date.
-0.26
75.70%
-0.49
-88.46%
-0.63
-28.57%
-0.64
-2.19%
-0.39
39.38%
-0.25
35.96%
0.04
116.17%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.16
44.06%
-0.20
21.82%
-0.01
-141.01%
-0.13
47.60%
-0.09
45.30%
-0.12
39.44%
0.10
896.39%
-0.01
93.83%
-0.01
93.17%
-0.07
45.03%
Revenue
Q2Q % growth
1.441B
-0.68%
1.474B
-3.18%
1.633B
6.54%
1.542B
10.54%
1.578B
9.51%
1.631B
10.65%
1.997B
22.29%
1.945B
26.13%
1.938B
22.81%
2.045B
25.38%
EBITDA
Q2Q % growth
-50.829M
56.01%
-63.842M
20.24%
18.822M
223.55%
-33.493M
67.11%
-26.461M
47.94%
-37.302M
41.57%
53.754M
185.59%
-3.709M
88.93%
-4.523M
82.91%
-38.175M
-2.34%
EBIT
Q2Q % growth
-83.597M
37.38%
-99.152M
5.12%
-16.108M
27.14%
-47.046M
59.45%
-52.579M
37.10%
-64.778M
34.67%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.25
-257.14%
-0.12-0.13-114.66%
Q1 2025
Q2Q % growth
0.03
400.00%
-0.010.04422.51%
Q4 2024
Q2Q % growth
-0.26
36.59%
-0.23-0.03-12.63%
Q3 2024
Q2Q % growth
-0.29
-262.50%
-0.11-0.18-171.08%
Q2 2024
Q2Q % growth
-0.07
-75.00%
-0.080.0114.11%
Q1 2024
Q2Q % growth
-0.01
-125.00%
-0.010.0018.64%
Q4 2023
Q2Q % growth
-0.41
-192.86%
-0.30-0.11-34.90%
Q3 2023
Q2Q % growth
-0.08
-14.29%
-0.06-0.02-39.16%
Q2 2023
Q2Q % growth
-0.04
20.00%
-0.03-0.01-55.98%
Q1 2023
Q2Q % growth
0.04 0.020.0281.50%
Q4 2022
Q2Q % growth
-0.14 -0.09-0.05-61.18%
Q3 2022
Q2Q % growth
-0.07
22.22%
-0.05-0.02-38.61%
Q2 2022
Q2Q % growth
-0.05
93.67%
-0.02-0.03-175.03%
Q1 2022
Q2Q % growth
0.00
100.00%
0.000.00-100.00%
Q4 2021
Q2Q % growth
-0.14 -0.11-0.03-26.01%
Q3 2021
Q2Q % growth
-0.09 -0.100.017.82%
Q2 2021
Q2Q % growth
-0.79 -0.06-0.73-1,322.14%
Q1 2021
Q2Q % growth
-0.05 -0.03-0.02-65.02%
AGL Yearly EPS VS EstimatesAGL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4 -0.6 -0.8 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
1.395B
-5.92%
1.486B-91.018M-6.13%
Q1 2025
Q2Q % growth
1.533B
-4.46%
1.519B13.782M0.91%
Q4 2024
Q2Q % growth
1.522B
44.16%
1.531B-8.514M-0.56%
Q3 2024
Q2Q % growth
1.451B
19.35%
1.485B-34.068M-2.29%
Q2 2024
Q2Q % growth
1.483B
29.04%
1.575B-92.242M-5.86%
Q1 2024
Q2Q % growth
1.604B
41.21%
1.62B-15.646M-0.97%
Q4 2023
Q2Q % growth
1.056B
53.10%
1.028B28.073M2.73%
Q3 2023
Q2Q % growth
1.216B
74.94%
1.149B66.66M5.80%
Q2 2023
Q2Q % growth
1.149B
71.47%
1.122B27.052M2.41%
Q1 2023
Q2Q % growth
1.136B
73.88%
1.089B47.147M4.33%
Q4 2022
Q2Q % growth
689.8M
49.02%
671M18.8M2.80%
Q3 2022
Q2Q % growth
694.9M
51.53%
660.61M34.29M5.19%
Q2 2022
Q2Q % growth
670.1M
34.29%
654.46M15.64M2.39%
Q1 2022
Q2Q % growth
653.4M
58.17%
648.65M4.75M0.73%
Q4 2021
Q2Q % growth
462.9M 457.42M5.48M1.20%
Q3 2021
Q2Q % growth
458.6M
46.66%
454.85M3.75M0.82%
Q2 2021
Q2Q % growth
499M
69.96%
478.03M20.97M4.39%
Q1 2021
Q2Q % growth
413.1M
41.96%
409.55M3.55M0.87%
AGL Yearly Revenue VS EstimatesAGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -45.91% 0.81% -85.48%
Revenue-0.41% -2.57% -0.19% -2.38%